Kimia Therapeutics
Kimia is a drug discovery company applying high throughput precision chemistry in combination.
Kimia Therapeutics is a business in biotechnology, therapeutics based in San Francisco Bay Area, West Coast, Western US, founded in 2022.
Kimia Therapeutics is positioned in biotechnology, therapeutics, a segment that rewards a clear, focused offering.
The business is associated with San Francisco Bay Area, West Coast, Western US.
Its current recorded stage is Series_A.
Its team size is recorded as c_00011_00050 employees.
Total disclosed funding stands at about $55M.
| Sector | Biotechnology, Therapeutics |
|---|---|
| Headquarters | San Francisco Bay Area, West Coast, Western US |
| Founded | 2022 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $55,000,000 |
Website: www.kimiatx.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account